Properties, Contraindications, and Uses of St. John’s Wort (*Hypericum perforatum*)

The aerial parts of *Hypericum perforatum* (St. John’s wort) constitute a rich source of bioactive secondary metabolites whose pharmacological spectrum encompasses **neurotransmitter modulation** alongside **antiproliferative and anti-inflammatory effects**. Key compound classes include: **hypericin** (the pigment responsible for the extract’s distinctive red hue) and **hyperforin** (a primary quality marker), as well as **flavonoids** (e.g., quercetin, rutin), **xanthones**, **chlorogenic acid**, **procyanidins**, and **terpenes**. Clinical and preclinical evidence confirms that St. John’s wort extracts exhibit **antidepressant efficacy comparable to selective serotonin reuptake inhibitors (SSRIs)**, attributed to a **multimodal impact on serotonergic, noradrenergic, and dopaminergic systems**—primarily via **non-selective inhibition of monoamine transporters** (SERT, NET, DAT) and **modulation of catabolic enzymes** (MAO-A/B). Additionally, **interactions with GABA_A, NMDA, and adenosine receptors** have been documented, potentially underlying its anxiolytic and neuroprotective properties. In the pharmaceutical market, St. John’s wort preparations are predominantly available as **standardized extracts (containing 3–5% hypericin) in coated tablets, gelatin capsules, or hydroalcoholic tinctures**, with efficacy and safety contingent upon dosage and raw material quality.

Therapeutic use of St. John’s wort (*Hypericum perforatum*) necessitates strict avoidance of prolonged sun exposure, as the plant’s active constituent, hypericin, may trigger phototoxic reactions manifesting as cutaneous irritation or severe sunburn. Individuals with Fitzpatrick skin types I or II—characterized by fair complexion, freckling, and heightened susceptibility to ultraviolet damage—must exercise extreme caution, refraining entirely from tanning during supplementation. Furthermore, due to its complex pharmacokinetic profile, St. John’s wort significantly alters the metabolism of numerous pharmaceutical agents, mandating prior consultation with a healthcare provider. Of particular concern is its synergistic interaction with selective serotonin reuptake inhibitors (SSRIs), which may exacerbate adverse effects such as gastrointestinal distress, cephalalgia, or affective lability. Concurrent use with oral contraceptives is categorically contraindicated owing to the risk of diminished efficacy, while combination with anticoagulants (e.g., warfarin) may disrupt coagulation parameters. Absolute prohibitions extend to pregnant or lactating women, patients with advanced renal or hepatic impairment, and individuals undergoing immunosuppressive therapy. Given the potential for severe adverse interactions, any incorporation of St. John’s wort into a treatment regimen must be preceded by a comprehensive review of medical history and concurrent medications.

Due to its distinctive pharmacological properties, St. John’s wort plays a significant role in the management of mild to moderate depressive disorders. Clinical trials conducted among patients with these conditions have demonstrated that extracts of this herb lead to substantial improvements in mental well-being, with efficacy often comparable to that of conventional antidepressant medications. While some individuals undergoing treatment experienced adverse reactions—such as heightened skin sensitivity to ultraviolet radiation or gastrointestinal disturbances—it is noteworthy that therapy with St. John’s wort did not result in weight gain, a common side effect associated with synthetic pharmaceutical agents. Additionally, the herb is employed to alleviate symptoms of premenstrual syndrome, including mood swings, irritability, tearfulness, and anxiety. Preclinical research also suggests potential anticancer properties of hyperforin, one of the primary active compounds in St. John’s wort, which induces apoptosis in leukemic cells and inhibits their metastatic potential, although the precise mechanisms underlying these effects remain under scientific investigation. The plant further exhibits antibacterial activity, making it a valuable component in formulations designed to accelerate the healing of chronic wounds and ulcers. Its extracts are also widely incorporated into dermocosmetic products, intimate hygiene solutions, and oral rinses. Furthermore, St. John’s wort demonstrates spasmolytic effects and supports digestive processes, rendering it useful in the treatment of various gastrointestinal ailments, such as bloating, spasmodic pain, and impaired intestinal motility.

The most pharmacologically valuable botanical material is the flowering aerial parts of *Hypericum perforatum* (common St. John’s wort), which are harvested at the peak of the plant’s vegetative cycle. This period typically occurs in the latter half of June, earning the herb its colloquial name "St. John’s wort" in reference to the Feast of the Nativity of John the Baptist celebrated on June 24. Following the precise removal of the apical shoot segments, the plant undergoes a secondary flowering phase, permitting a second harvest within the same growing season. The freshly cut portions are arranged in single, non-compacted layers—either in specialized drying facilities with regulated airflow or under ambient conditions—and subjected to air-drying in shaded, well-ventilated environments with meticulously controlled temperatures not exceeding 35°C. Adherence to this thermal threshold is critical, as elevated temperatures may induce the degradation of heat-sensitive bioactive compounds, including hypericin and hyperforin, which underpin the herb’s therapeutic efficacy.

An infusion prepared from dried St. John’s wort (*Hypericum perforatum*) may serve as a valuable adjunct to daily nutrition, particularly when consumed postprandially, as it facilitates digestive processes and reduces the likelihood of gastrointestinal discomfort such as excessive gas accumulation. The tea can be prepared independently using dried plant material or by steeping pre-packaged sachets available at pharmacies. A critical consideration is avoiding the use of boiling water; instead, hot (non-boiling) water should be employed to preserve the plant’s therapeutically active compounds. When consumed in the evening, the infusion exhibits calming properties, alleviates nervous tension, and promotes easier onset of sleep, thereby enhancing overall sleep quality. St. John’s wort is among the most extensively studied medicinal herbs, with documented effects on both the digestive and nervous systems. Due to its potential interactions with multiple drug classes—including antidepressants, anticoagulants, and immunosuppressants—its use should always be discussed with a healthcare provider or pharmacist to preclude adverse synergistic or antagonistic reactions.